Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1681
| Despition | CALN1 Human Recombinant |
| SIZE | 1 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1388 | Human FDX1 Protein (AC1388) | 5 µg | inquiry |
| ACPP-1788 | Human NEUROG3 Protein (AC1788) | 2 µg | inquiry |
| ACPP-1848 | Human MTPN Protein (AC1848) | 5 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1573 | Human YWHAG Protein, His (AC1573) | 2 µg | inquiry |
| ACPP-1459 | Human Midkine Protein, His (AC1459) | 5 µg | inquiry |
| ACPP-1026 | Recombinant Human Neuropilin 1 Protein (6×His Tag) (AC1026) | 50 µg | inquiry |
| ACPP-1369 | Parkin Blocking Peptide (AC1369) | 250 µg | inquiry |
| ACPP-1012 | Recombinant Human Ninjurin 1 Protein (Fc Tag) (AC1012) | 50 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.